Back to top

Appendix 4C -- Q4 FY25 Quarterly Cash Flow Report | ATHE Stock News

Appendix 4C -- Q4 FY25 Quarterly Cash Flow Report | ATHE Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Alterity Therapeutics Limited - Sponsored ADR (ATHE)